Curcumin enhances poly(ADP-ribose) polymerase inhibitor sensitivity to chemotherapy in breast cancer cells

The Journal of Nutritional Biochemistry
Young Eun Choi, Eunmi Park

Abstract

Poly(ADP-ribose) polymerase (PARP) inhibitor has shown promising responses in homologous recombination (HR) repair-deficient cancer cells. More specifically, targeting HR pathway in combination with PARP inhibitor has been an effective chemotherapy strategy by so far. Curcumin has been recognized as anticancer agents for several types of cancers. Here, we demonstrate that curcumin inhibits a critical step in HR pathway, Rad51 foci formation, and accumulates γ-H2AX levels in MDA-MB-231 breast cancer cells. Curcumin also directly reduces HR and induces cell death with cotreatment of PARP inhibitor in MDA-MB-231 breast cancer cells. Moreover, curcumin, when combined with ABT-888, could effectively delayed breast tumor formation in vivo. Our study indicates that cotreatment of curcumin and PARP inhibitor might be useful for the combination chemotherapy for aggressive breast cancer treatment as a natural bioactive compound.

References

Oct 29, 2004·Nature Reviews. Cancer·Nicholas TurnerAlan Ashworth
Jun 28, 2011·Nature Medicine·Neil JohnsonGeoffrey I Shapiro
Apr 28, 2012·Molecular Cancer·Céline JacquemontToshiyasu Taniguchi
Sep 25, 2012·Journal of Physiology and Biochemistry·Aysegul CortTomris Ozben
Nov 3, 2012·Current Pharmaceutical Design·Chunfen YangGuangxi Zhai
Nov 13, 2012·The AAPS Journal·Subash C GuptaBharat B Aggarwal
Jun 29, 2013·Molecular Cell·Eunmi ParkAlan D D'Andrea
Sep 5, 2013·Molecular and Cellular Biology·Eunmi ParkAlan D D'Andrea
Dec 17, 2014·Current Topics in Medicinal Chemistry·Tomris Ozben
Feb 5, 2015·Nutrition and Cancer·Aysegul Cort, Tomris Ozben
Mar 10, 2015·International Journal of Endocrinology and Metabolism·Zeinab GhorbaniParvin Mirmiran

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.